Selvita S.A. (WSE:SLV)

Poland flag Poland · Delayed Price · Currency is PLN
32.60
-0.30 (-0.91%)
Aug 14, 2025, 1:43 PM CET
-47.08%
Market Cap 603.90M
Revenue (ttm) 359.79M
Net Income (ttm) -4.95M
Shares Out 18.36M
EPS (ttm) -0.27
PE Ratio n/a
Forward PE 79.44
Dividend n/a
Ex-Dividend Date n/a
Volume 15,683
Average Volume 52,671
Open 33.00
Previous Close 32.90
Day's Range 32.30 - 33.00
52-Week Range 26.50 - 67.00
Beta 0.07
RSI 47.80
Earnings Date Sep 12, 2025

About Selvita

Selvita S.A. operates as a contract research organization worldwide. The company offers drug discovery services in the areas of AI-driven drug discovery, antibody drug discovery, structural biology, recombinant protein production, assay development and screening, computer-aided drug design, medicinal and synthetic chemistry, scale-up, ADME/DMPK, in vitro and In Vivo pharmacology, translational research, and toxicology. It also develops drugs for therapeutic areas, such as oncology, infectious diseases, immunology, neurology, respiratory, and ot... [Read more]

Sector Healthcare
Founded 2007
Employees 969
Stock Exchange Warsaw Stock Exchange
Ticker Symbol SLV
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.